We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H...
Read moreWe outline the challenges pharma companies encounter when launching cell and gene therapies, and ass...
Read moreThis article explores the new EU pharmaceutical package and criteria of high unmet medical need (HUM...
Read moreThis article explores the significant disparities between the US and Europe regarding orphan drugs a...
Read moreOur market access experts provide an overview of how to get payer scientific advice between Septembe...
Read moreWe explore the innovative assessment criteria for novel cancer therapies and the unmet needs in onco...
Read moreWe explore the issues faced by manufacturers and payers for oncology combination pricing and the pot...
Read moreWe explore the rapidly evolving market access landscape in respect to digital health applications in...
Read moreDigital health technology played a vital role during the COVID-19 pandemic as there was a rapid usag...
Read moreWe explore the coordinated HTA networks involved in EUnetHTA, define the HTACG and the deliverables ...
Read more